Roche - About the company
Roche is a public company based in Basel (Switzerland), founded in 1896 by Fritz Hoffmann La Roche. It operates as a Developer of pharmaceuticals and diagnostics kits. Roche has raised an undisclosed amount in funding. The company has 2163 active competitors, including 140 funded and 235 that have exited. Its top competitors include companies like AbbVie, Amgen and Gilead.
Company Details
Developer of pharmaceuticals and diagnostics kits for multiple diseases. It manufactures diagnostic equipment and reagents for research and medical diagnostic applications. In 2022, the company recorded annual revenues of $66.26B and a net profit of $13.01B
- Website
- www.roche.com/
- Email ID
- *****@roche.com
- Phone Number
- +41 **********
- Registered Address
- Little Falls, New Jersey
Key Metrics
Founded Year
1896
Location
Basel, Switzerland
Stage
Public
Latest Funding Round
Investors
Ranked
9th among 2163 active competitors
Annual Revenue
£10M - £50M as on Jul 31, 2022
Employee Count
105,566 as on May 31, 2026
Exit Details
Public
Legal entities associated with Roche
Roche is associated with 29 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
ROCHE DIAGNOSTICS GMBH CIN: 929234677 , Norway, Active | Jul 22, 1920 | - | - | |
ROCHE PRODUCTS (INDIA) PRIVATE LIMITED CIN: U74999MH1994PTC077533 , India, Active | Apr 05, 1994 | ₹1,000+ Cr (As on Mar 31, 2025) | 284 (As on Mar 01, 2026) | |
ROCHE HEALTHCARE LIMITED CIN: 2992723 , United Kingdom, Active | Nov 20, 1994 | £10M - £50M (As on Jul 31, 2022) | 365 (As on Jul 31, 2022) | |
ROCHE INDIA HEALTHCARE INSTITUTE CIN: U85320MH2019NPL330482 , India, Active | Sep 12, 2019 | 0 - ₹10 Cr (As on Mar 31, 2025) | - | |
F. Hoffmann-La Roche Ltd CIN: 105.815.381 , Switzerland, Active | Sep 30, 1896 | - | - | - |
Swiss Pharma PLUS s.r.o. CIN: 19721692 , Czech Republic, Active | Sep 13, 2023 | - | - | |
Biopharma-design s.r.o. CIN: 06139825 , Czech Republic, Active | May 31, 2017 | - | - | |
Roxx International s.r.o. CIN: 27192474 , Czech Republic, Active | Nov 02, 2004 | - | - | |
International PTR s.r.o. CIN: 07756046 , Czech Republic, Active | Jan 02, 2019 | - | - | |
TEHREN INVEST s.r.o. CIN: 19945167 , Czech Republic, Active | Nov 21, 2023 | - | - | |
International Trade Company s.r.o. CIN: 06303412 , Czech Republic, Active | Jul 27, 2017 | - | - | |
SANDORTE trade s.r.o. CIN: 07439903 , Czech Republic, Active | Sep 06, 2018 | - | - | |
K.H.A. Invest s.r.o. CIN: 27419479 , Czech Republic, Active | Jan 26, 2006 | - | - | |
Roche Real Invest, s.r.o. CIN: 07857691 , Czech Republic, Active | Feb 01, 2019 | - | - | |
Roche Privacy GmbH CIN: B8536_HRB718233 , Germany, Active | Jun 08, 2018 | - | - | |
Hoffmann-la Roche Inc. CIN: 220994270 , United States, Active | Dec 26, 999 | - | 1760 (As on Dec 31, 2024) | - |
ROCHE DIAGNOSTICS (THAILAND) LTD. CIN: 0105535102139 , Thailand, Active | Jul 13, 1992 | $100M - $500M (As on Dec 31, 2023) | - | |
ROCHE -BOBOIS USA LIMITED CIN: 132788222 , United States, Active | Dec 31, 1999 | - | 227 (As on Dec 31, 2024) | - |
ROCHE DIAGNOSTICS INDIA PRIVATE LIMITED CIN: U85195MH1988PTC141417 , India, Active | Jun 07, 1988 | ₹1,000+ Cr (As on Mar 31, 2025) | 442 (As on May 01, 2026) | |
F.group partner, s.r.o. CIN: 19284357 , Czech Republic, Active | Apr 26, 2023 | - | - | |
GS pharma s. r. o. CIN: 27502953 , Czech Republic, Active | Oct 10, 2006 | - | - | |
ROCHE ENGINEERING LTD CIN: 12649092 , United Kingdom, Active | Jun 04, 2020 | £0 - £1M (As on Jun 30, 2024) | 1 (As on Jun 30, 2024) | |
Diabetes Import s.r.o. CIN: 09831576 , Czech Republic, Active | Jan 16, 2021 | - | - | |
ROCHE SERVICES AND SOLUTIONS (INDIA) PRIVATE LIMITED CIN: U63119TS2023FTC177783 , India, Active | Oct 09, 2023 | ₹50 - ₹100 Cr (As on Mar 31, 2025) | - | |
EURO TRADING PRAGUE SYGMA s.r.o. CIN: 19268106 , Czech Republic, Active | Apr 20, 2023 | - | - | |
WORLD TRADING COMPANY s. r. o. CIN: 07789831 , Czech Republic, Active | Jan 10, 2019 | - | - | |
ROFU (THAILAND) COMPANY LIMITED CIN: 0105558123931 , Thailand, Active | Jul 29, 2015 | $50M - $100M (As on Dec 31, 2022) | - | |
La Group Market s.r.o. CIN: 19536925 , Czech Republic, Active | Aug 01, 2023 | - | - | |
AL-LA Praha,s.r.o. CIN: 25659642 , Czech Republic, Active | Apr 14, 1998 | - | - |
Roche's IPO details
Roche got listed on Dec 05, 2002.
Click here to take a look at Roche's IPO in detail
Sign up to download Roche's company profile
Roche's funding and investors
Roche has raised funding over 18 rounds. Its first funding round was on May 01, 2004. Its latest funding round was a Post IPO round on May 21, 2023 for $*****. 1 investor participated in its latest round. Roche has 13 institutional investors.
Here is the list of recent funding rounds of Roche:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
May 21, 2023 | 4064132 | Post IPO | 4960646 | 1771207 | 9666681 | 3590874 |
Jun 01, 2022 | 2071673 | Grant (prize money) | 6900740 | 5124186 | 2552980 | |
Aug 05, 2021 | 2359039 | Post IPO | 9645485 | 8951512 | 2044030 |
View details of Roche's funding rounds and investors
Roche's founders and board of directors
Founder? Claim ProfileThe founders of Roche is Fritz Hoffmann La Roche.
Here are the details of Roche's key team members:
- Fritz Hoffmann La Roche: Former Founder of Roche and founder of 1 other company.
Roche's Board of Directors
Roche's board has 4 active members. Alan Hippe, Claudia Böckstiegel and Thomas Schinecker are part of team and Urs Lauffer is independent board member.Here is the list of Roche's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
vscfprf | Team | - | Current | 4y 6m |
{ymuggu | Team | - | Current | 8y 5m |
gxhxfel | Team | - | Current | 5y 4m |
Independent board member | - | Current | - |
View details of Roche's Founder profiles and Board Members
Roche's employee count trend
Roche has 105,566 employees as of May 26. Here is Roche's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Roche's Competitors and alternates
Top competitors of Roche include AbbVie, Amgen and Gilead. Here is the list of Top 10 competitors of Roche, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | AbbVie 2012, Chicago (United States), Public | Research-based biopharmaceutical company | $14.7B | 81/100 | |
2nd | Amgen 1980, Thousand Oaks (United States), Public | Developer of pharmaceutical products for treating multiple diseases | - | 81/100 | |
3rd | Gilead 1987, Foster City (United States), Acquired | Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | - | 80/100 | |
4th | Lilly 1876, Indianapolis (United States), Public | Developer of traditional pharmaceutical medicines | - | 75/100 | |
5th | Johnson & Johnson 1886, New Brunswick (United States), Public | Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products | - | 74/100 | |
6th | AstraZeneca 1999, Cambridge (United Kingdom), Public | Developer of pharmaceutical medicines for oncology and various chronic diseases | - | 73/100 | |
7th | Novartis 1996, Basel (Switzerland), Acquired | R&D focused on manufacturing of drugs for multiple therapeutic areas | - | 71/100 | |
8th | Roivant Sciences 2014, New York City (United States), Public | Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases | $1.3B | 70/100 | |
9th | Roche 1896, Basel (Switzerland), Public | Developer of pharmaceuticals and diagnostics kits | - | 70/100 | |
10th | Genentech 1976, San Francisco (United States), Acquired | R&D company focused on manufacturing drugs for multiple therapeutic areas | $72.5M | 69/100 |
Looking for more details on Roche's competitors? Click here to see the top ones
Roche's Investments and acquisitions
Roche has made 44 investments in companies including Mironid and Mission Therapeutics. Roche has also acquired 49 companies including 89bio and Poseida Therapeutics.Here is the list of investments & acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Aug 05, 2026 | Investments | 2015 | Glasgow (United Kingdom) | |
Oct 15, 2025 | Investments | 2011 | Cambridge (United Kingdom) | |
Sep 17, 2025 | Acquisition | 2018 | San Francisco (United States) |
See all investments and acquisitions by Roche
News related to Roche
Media has covered Roche for a total of 227 events in the last 1 year, 82 of them have been about company updates and 29 about partnerships.
•
Mironid Secures $46M Series B Funding to Advance Rare Kidney Disease TreatmentGlobeNewswire•Aug 05, 2026•Mironid, BioGeneration Ventures, Epidarex Capital, The Scottish National Investment Bank and 3 others
•
Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation StudiesPR Newswire•Aug 03, 2026•Roche, Genprex, Evexta Bio
•
CHMP recommends EU approval of Roche’s Susvimo for neovascular age-related macular degenerationGlobeNewswire•Jul 24, 2026•Roche
•
Roche receives FDA clearance for cobas BV/CV assay for fast and accurate vaginitis diagnosisPR Newswire•Jul 24, 2026•Roche
•
•
•
•
•
Roche Appoints Dan Malarek as President and CEO of Roche Diagnostics North AmericaPR Newswire•Jul 20, 2026•Roche
•
Roche Gazyva/Gazyvaro Receives FDA Priority Review for Primary Membranous NephropathyGlobeNewswire•Jul 15, 2026•Roche
Are you a Founder ?
FAQs about Roche
Explore our recently published companies
- Bernierobbins - Unfunded company
- Baronhats - United States based, Unfunded company
- Nivmeh - 2023 founded, Unfunded company
- eldoLED - United States based, 2005 founded, Unfunded company
- Right E-Waste Recycle - Unfunded company
- Connect Info Solutions - Mumbai based, 2012 founded, Unfunded company
